Aimei Health Technology Co., Ltd is a leading innovator in the healthcare technology sector, leveraging artificial intelligence to transform patient care through advanced diagnostics and treatment solutions. The company's commitment to enhancing operational efficiencies within healthcare systems positions it strategically in a rapidly growing market driven by the increasing demand for digital health applications. Aimei's focus on developing next-generation products aimed at improving patient outcomes underscores its potential for sustainable growth, making it an appealing investment opportunity for institutional investors seeking to capitalize on the future of health technology.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.04% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -30.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $4.40M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |